Literature DB >> 12208959

Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16.

Clare E Davy1, Deborah J Jackson, Qian Wang, Kenneth Raj, Phillip J Masterson, Nicola F Fenner, Shirley Southern, Scott Cuthill, Jonathan B A Millar, John Doorbar.   

Abstract

Human papillomavirus type 16 (HPV16) is the most common cause of cervical carcinoma. Cervical cancer develops from low-grade lesions that support the productive stages of the virus life cycle. The 16E1 wedge E4 protein is abundantly expressed in such lesions and can be detected in cells supporting vegetative viral genome amplification. Using an inducible mammalian expression system, we have shown that 16E1 wedge E4 arrests HeLa cervical epithelial cells in G(2). 16E1 wedge E4 also caused a G(2) arrest in SiHa, Saos-2 and Saccharomyces pombe cells and, as with HeLa cells, was found in the cytoplasm. However, whereas 16E1 wedge E4 is found on the keratin networks in HeLa and SiHa cells, in Saos-2 and S. pombe cells that lack keratins, 16E1 wedge E4 had a punctate distribution. Mutagenesis studies revealed a proline-rich region between amino acids 17 and 45 of 16E1 wedge E4 to be important for arrest. This region, which we have termed the "arrest domain," contains a putative nuclear localization signal, a cyclin-binding motif, and a single cyclin-dependent kinase (Cdk) phosphorylation site. A single point mutation in the putative Cdk phosphorylation site (T23A) abolished 16E1 wedge E4-mediated G(2) arrest. Arrest did not involve proteins regulating the phosphorylation state of Cdc2 and does not appear to involve the activation of the DNA damage or incomplete replication checkpoint. G(2) arrest was also mediated by the E1 wedge E4 protein of HPV11, a low-risk mucosal HPV type that also causes cervical lesions. The E1 wedge E4 protein of HPV1, which is more distantly related to that of HPV16, did not cause G(2) arrest. We conclude that, like other papillomavirus proteins, 16E1 wedge E4 affects cell cycle progression and that it targets a conserved component of the cell cycle machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208959      PMCID: PMC136512          DOI: 10.1128/jvi.76.19.9806-9818.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection.

Authors:  K Brand; R Klocke; A Possling; D Paul; M Strauss
Journal:  Gene Ther       Date:  1999-06       Impact factor: 5.250

2.  Human Papillomavirus. Introduction.

Authors:  E M de Villiers
Journal:  Semin Cancer Biol       Date:  1999-12       Impact factor: 15.707

3.  Quantitation of papova virus particles in human warts.

Authors:  J G BARRERA-ORO; K O SMITH; J L MELNICK
Journal:  J Natl Cancer Inst       Date:  1962-09       Impact factor: 13.506

4.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

5.  HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.

Authors:  W C Goh; M E Rogel; C M Kinsey; S F Michael; P N Fultz; M A Nowak; B H Hahn; M Emerman
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

6.  Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr.

Authors:  M Masuda; Y Nagai; N Oshima; K Tanaka; H Murakami; H Igarashi; H Okayama
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4.

Authors:  J Doorbar; C Foo; N Coleman; L Medcalf; O Hartley; T Prospero; S Napthine; J Sterling; G Winter; H Griffin
Journal:  Virology       Date:  1997-11-10       Impact factor: 3.616

8.  Cyclin A-dependent kinase activity affects chromatin binding of ORC, Cdc6, and MCM in egg extracts of Xenopus laevis.

Authors:  M Findeisen; M El-Denary; T Kapitza; R Graf; U Strausfeld
Journal:  Eur J Biochem       Date:  1999-09

9.  The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.

Authors:  P M Day; R B Roden; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins.

Authors:  N O Ku; J Liao; M B Omary
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

View more
  38 in total

1.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

Review 2.  The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.

Authors:  D M D'Agostino; M Silic-Benussi; H Hiraragi; M D Lairmore; V Ciminale
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

3.  Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.

Authors:  Regina Wilson; Frauke Fehrmann; Laimonis A Laimins
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Authors:  Jameela Khan; Clare E Davy; Pauline B McIntosh; Deborah J Jackson; Steven Hinz; Qian Wang; John Doorbar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 5.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

6.  The small splice variant of HPV16 E6, E6, reduces tumor formation in cervical carcinoma xenografts.

Authors:  Maria Filippova; Whitney Evans; Robert Aragon; Valery Filippov; Vonetta M Williams; Linda Hong; Mark E Reeves; Penelope Duerksen-Hughes
Journal:  Virology       Date:  2014-01-01       Impact factor: 3.616

7.  Human papillomavirus 18 E1^E4 protein interacts with cyclin A/CDK 2 through an RXL motif.

Authors:  Qingming Ding; Lili Li; Peter Whyte
Journal:  Mol Cell Biochem       Date:  2012-10-13       Impact factor: 3.396

8.  Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.

Authors:  Sohrab Bodaghi; Rong Jia; Zhi-Ming Zheng
Journal:  Virology       Date:  2009-02-01       Impact factor: 3.616

9.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 10.  Human papillomaviruses and the interferon response.

Authors:  Melanie Beglin; Marta Melar-New; Laimonis Laimins
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.